ARWR compared with KRYS: revenue, margins and what each company keeps, and the suppliers and customers both name

ARWRArrowhead Pharmaceuticals, Inc.

Mkt capRevenueRevenue

KRYSKrystal Biotech, Inc.

Mkt capRevenueRevenue

Compare

ARWRArrowhead Pharmaceuticals, Inc.

KRYSKrystal Biotech, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Co-movers

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Co-movers

daily closes · 501dMethod ›

Moved together

ARWRwithKRYS

×0.20co-movement · KRYS on ARWR · 501d

r 0.32scale to r 0.75

Shared co-movers3with ARWRwith KRYS

DNLIDenali Therapeutics Inc.r 0.49r 0.40

SYRESpyre Therapeutics, Inc.r 0.40r 0.39

BEAMBeam Therapeutics Inc.r 0.45r 0.39

ARWR, solidKRYS, hatched× = co-movement · βr = correlationBar = r to r 0.75Order: weaker of A and BSource: daily closes

ARWRArrowhead Pharmaceuticals, Inc.

60.68▲+1.31%· post 59.68

Mkt cap$8.5BRevenue$75MQ3 FY26Revenue$829MFY25

KRYSKrystal Biotech, Inc.

295.30▼−11.13%· post 295.27

ClosedNov 2 '26

Mkt cap$9.8BRevenue$127MQ3 FY26Revenue$389MFY25

Compare

ClosedNov 2 '26

ARWRArrowhead Pharmaceuticals, Inc.

KRYSKrystal Biotech, Inc.

60.68▲+1.31%post 59.68

Price

295.30▼−11.13%post 295.27

$8.5B

Mkt cap

$9.8B

Q3 FY26$75M

Revenue

$127MQ3 FY26

FY25$829M

Revenue

$389MFY25

ARWR60.68▲+1.31%vsKRYS295.30▼−11.13%ClosedNov 2 '26